Abiomed wins US FDA approval for new Impella product

By Admin
Abiomed Inc said it has secured approval from the U.S. Food and Drug Administration for its new Impella product dubbed Impella CP (Cardiac Power). The...

Abiomed Inc said it has secured approval from the U.S. Food and Drug Administration for its new Impella product dubbed Impella CP (Cardiac Power).

The product is known by the name of Impella cVADoutside U.S. This device can pump as much as 80% of blood into the heart in a minute compared to a normal heart and is suitable for heart patients that require greater hemodynamic support.

With the much anticipated launch of the device Impella CP in the U.S., Maschusetts-based heart support Technologies Company will be able to further expand its presence in the clinical devices market.

Abiomed initially plans to sell the product to well-known heart hospitals in the U.S. Impella CP is likely to be commercially available in the U.S. by the fourth quarter of fiscal 2013.

 The heart support technologies company also announced the first successful human use of Impella cVADoutside the U.S. in April.

Abiomed is enjoying strong demand for its Impella products. Global sales of Impella rose 56% year over year to $34.7 million in the last reported quarter. The sales of Impella in U.S. spiked 61% to $33 million. It also opened 34 new U.S. Impella 2.5 sites in the quarter to end with a total of 665 customer sites.

Abiomed is a global leader in healthcare technology and innovation.

Share
Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML